US 9592290
Monoclonal antibody therapy for pancreas cancer
granted A61KA61K2039/505A61K39/39558
Quick answer
US patent 9592290 (Monoclonal antibody therapy for pancreas cancer) held by PRECISION BIOLOGICS, INC. expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PRECISION BIOLOGICS, INC.
- Grant date
- Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K39/39558, A61K47/6859, A61K49/04